Previous studies have found that in breast cancer, PDGFRB+CAFs recruit CD4+CD25+FOXP3+ Treg cells, and the recruited Treg cells inhibit the activation and proliferation of CD8+T cells in the TME, thereby inducing local immunosuppression (63). This evidence concerns the gene FOXP3 and breast cancer.